Umut Onat

Array ( [id] => 3658848 [patent_doc_number] => 05623056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'CDS derivatives and methods of use for cellular modulation and enhancement of cellular engraftment' [patent_app_type] => 1 [patent_app_number] => 8/174583 [patent_app_country] => US [patent_app_date] => 1993-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9523 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/623/05623056.pdf [firstpage_image] =>[orig_patent_app_number] => 174583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3719978 [patent_doc_number] => 05672350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/171763 [patent_app_country] => US [patent_app_date] => 1993-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 15234 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672350.pdf [firstpage_image] =>[orig_patent_app_number] => 171763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471875 [patent_doc_number] => 05476785 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from Plasmodium falciparum' [patent_app_type] => 1 [patent_app_number] => 8/161406 [patent_app_country] => US [patent_app_date] => 1993-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3251 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476785.pdf [firstpage_image] =>[orig_patent_app_number] => 161406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4094235 [patent_doc_number] => 06048531 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies' [patent_app_type] => 1 [patent_app_number] => 8/160093 [patent_app_country] => US [patent_app_date] => 1993-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10770 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048531.pdf [firstpage_image] =>[orig_patent_app_number] => 160093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176484 [patent_doc_number] => 06037135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Methods for making HLA binding peptides and their uses' [patent_app_type] => 1 [patent_app_number] => 8/159339 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 36 [patent_no_of_words] => 110413 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037135.pdf [firstpage_image] =>[orig_patent_app_number] => 159339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109464 [patent_doc_number] => 06022966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Pretargeting methods and compounds' [patent_app_type] => 1 [patent_app_number] => 8/156565 [patent_app_country] => US [patent_app_date] => 1993-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 36739 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022966.pdf [firstpage_image] =>[orig_patent_app_number] => 156565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3108942 [patent_doc_number] => 05395614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-07 [patent_title] => 'Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/152922 [patent_app_country] => US [patent_app_date] => 1993-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3760 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/395/05395614.pdf [firstpage_image] =>[orig_patent_app_number] => 152922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3598275 [patent_doc_number] => 05578303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Diagnosis and treatment of insulin dependent diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/151052 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16620 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578303.pdf [firstpage_image] =>[orig_patent_app_number] => 151052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980185 [patent_doc_number] => 05861164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Vaccination against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/146454 [patent_app_country] => US [patent_app_date] => 1993-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5143 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861164.pdf [firstpage_image] =>[orig_patent_app_number] => 146454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808281 [patent_doc_number] => 05831036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Soluble fragments of human intercellular adhesion molecule-1' [patent_app_type] => 1 [patent_app_number] => 8/140554 [patent_app_country] => US [patent_app_date] => 1993-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 33 [patent_no_of_words] => 45959 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831036.pdf [firstpage_image] =>[orig_patent_app_number] => 140554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604625 [patent_doc_number] => 05578714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'DNA encoding Duffy 9pd protein' [patent_app_type] => 1 [patent_app_number] => 8/140797 [patent_app_country] => US [patent_app_date] => 1993-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 8369 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578714.pdf [firstpage_image] =>[orig_patent_app_number] => 140797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588315 [patent_doc_number] => 05585268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Malaria-specific DNA sequences, expression products thereof, and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/128269 [patent_app_country] => US [patent_app_date] => 1993-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585268.pdf [firstpage_image] =>[orig_patent_app_number] => 128269 [rel_patent_id] =>[rel_patent_doc_number] =>)